Showing results (101-110 of 205) with videos related to

Sort By:
Pageof 21
The Journal of Clinical Investigation|December 11, 2012
Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant miceTiffany Chang, Kimberly Krisman, Emily Harding Theobald, et al.
Cell Chemical Biology|March 12, 2026
De novo design of Ras isoform selective bindersJason Z Zhang, Xinting Li, Alexa Rane Batingana, et al.
Leukemia Research|December 31, 2013
Phase I evaluation of XL019, an oral, potent, and selective JAK2 inhibitorSrdan Verstovsek, Constantine S Tam, Martha Wadleigh, et al.
Heart Rhythm|February 2, 2023
Functional characterization and identification of a therapeutic for a novel SCN5A-F1760C variant causing type 3 long QT syndrome refractory to all guideline-directed therapiesMarissa J Stutzman, Xiaozhi Gao, Maengjo Kim, et al.
Congenital Heart Disease|November 20, 2010
Arrhythmia recurrence in adult patients with single ventricle physiology following surgical Fontan conversionJamil Aboulhosn, Ryan Williams, Kalyanam Shivkumar, et al.
Plos Biology|March 20, 2009
Oncogenic Kras initiates leukemia in hematopoietic stem cellsAmit J Sabnis, Laurene S Cheung, Monique Dail, et al.
Blood Advances|March 10, 2023
Opposing effects of KDM6A and JDP2 on glucocorticoid sensitivity in T-ALLAnya L Levinson, Karensa Tjoa, Benjamin Huang, et al.
Blood|February 27, 2014
Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 studyNeil P Shah, François Guilhot, Jorge E Cortes, et al.
Haematologica|May 17, 2020
Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia modelsRaghuveer Singh Mali, Qi Zhang, Rosa Anna DeFilippis, et al.
Cell Host & Microbe|June 25, 2024
Discovery of disease-adapted bacterial lineages in inflammatory bowel diseasesAdarsh Kumbhari, Thomas N H Cheng, Ashwin N Ananthakrishnan, et al.
Pageof 21